MedTrace Logo

Evaluation of Low-Level Light Therapy on Meibomian Glands Study

NCT05859295 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-12-07

No results posted yet for this study

Summary

The goal of this clinical trial is to examine the effect of low-level light therapy (LLLT) on meibomian gland dysfunction and dry eye disease. The main questions it aims to answer are:

1. Does low-level light therapy reduce levels of pro-inflammatory proteins in meibum
2. Does low-level light therapy increase the ratio of non-polar lipids to polar lipids in meibum

Participants will receive 3 15-minute sessions of low-level light therapy. Meibum will be collected before the first treatment and after the final treatment.

Conditions

  • Meibomian Gland Dysfunction
  • Dry Eye

Interventions

DEVICE

Red Low-Level Light Therapy

Visible red light (633nm) projected onto the face using an light emitting diode (LED) mask

Sponsors & Collaborators

  • University of Louisville

    collaborator OTHER

  • University of Houston

    lead OTHER

Principal Investigators

  • Eric R Ritchey, OD, PhD · The University of Houston College of Optometry

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-07
Primary Completion
2023-11-11
Completion
2023-11-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05859295 on ClinicalTrials.gov